Anika Therapeutics Inc (ANIK):企業の製品パイプライン分析2018

GlobalDataが発行した調査報告書(DATA904C5279)
◆英語タイトル:Anika Therapeutics Inc (ANIK) - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C5279
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年9月
◆ページ数:51
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Anika Therapeutics Inc (Anika) develops, manufactures, and markets therapeutic products for tissue protection, repair and regeneration. It offers solutions for orthobiologics, dermal, ophthalmic, surgical and veterinary applications. Its major products include viscosupplementation and regenerative orthopedics products, advanced wound care devices, anti-adhesion gels, viscoelastic ophthalmic products, dental bone grafting adjuncts and joint dysfunction management fluids for horses. Its products are made from hyaluronic acid (HA) based on two technologies: HYAFF, which is a solid form of HA, and ACP gel, an autocross-linked polymer of HA. Anika has research and manufacturing facilities in Bedford, Massachusetts. The company offers its products through distributors in the Americas, Europe, the Middle East, and Asia. Anika is headquartered in Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Anika Therapeutics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Anika Therapeutics Inc Company Overview 6
Anika Therapeutics Inc Company Snapshot 6
Anika Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview 6
Anika Therapeutics Inc – Pipeline Analysis Overview 9
Business Description 9
Anika Therapeutics Inc – Key Facts 9
Anika Therapeutics Inc – Major Products and Services 10
Anika Therapeutics Inc Pipeline Products by Development Stage 12
Anika Therapeutics Inc Ongoing Clinical Trials by Trial Status 14
Anika Therapeutics Inc Pipeline Products Overview 16
Cingal 16
Cingal Product Overview 16
Drug Delivery System 17
Drug Delivery System Product Overview 17
Hemostatic Patch 18
Hemostatic Patch Product Overview 18
HYAFF – Rotator Cuff Repair 19
HYAFF – Rotator Cuff Repair Product Overview 19
HYAFF Barrier Film 20
HYAFF Barrier Film Product Overview 20
HYAFF Gel 21
HYAFF Gel Product Overview 21
HYAFF Mesh 22
HYAFF Mesh Product Overview 22
Hyalobone 23
Hyalobone Product Overview 23
Hyalofast 24
Hyalofast Product Overview 24
Hyalofast Clinical Trial 25
Hyaloglide 26
Hyaloglide Product Overview 26
Hyalograft C Autograft 27
Hyalograft C Autograft Product Overview 27
Hyalonect 28
Hyalonect Product Overview 28
Hyaluronic Acid – Synovial Joints 29
Hyaluronic Acid – Synovial Joints Product Overview 29
MONOVISC 30
MONOVISC Product Overview 30
MONOVISC – Hip 31
MONOVISC – Hip Product Overview 31
MONOVISC – Hip Clinical Trial 32
Next Generation ELEVESS Dermal Filler 33
Next Generation ELEVESS Dermal Filler Product Overview 33
ORTHOVISC-T 34
ORTHOVISC-T Product Overview 34
SCS 17-01 35
SCS 17-01 Product Overview 35
Anika Therapeutics Inc – Key Competitors 36
Anika Therapeutics Inc – Key Employees 37
Anika Therapeutics Inc – Key Employee Biographies 38
Anika Therapeutics Inc – Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Recent Developments 40
Anika Therapeutics Inc, Recent Developments 40
Jun 19, 2018: Anika Therapeutics Announces Top-Line Results from CINGAL 16-02 Clinical Trial in Knee Osteoarthritis 40
May 08, 2018: Anika to Showcase Commercial and Pipeline Portfolio at 18th Bi-Annual European Society for Sports Traumatology, Knee Surgery and Arthroscopy Congress 40
May 02, 2018: Anika Reports First Quarter 2018 Financial Results 41
Apr 24, 2018: Amplify What’s Possible: Medline to Highlight Holistic Approach to Wound Care and Skin Health at Symposium on Advanced Wound Care 42
Apr 06, 2018: Anika Announces Plans to Showcase HYALOFAST Hyaluronic Acid-Based Scaffold at the 2018 World Congress of the International Cartilage Repair Society 43
Mar 05, 2018: Anika Therapeutics Names Joseph Darling As CEO And Director 44
Feb 21, 2018: Anika Announces Fourth Quarter and Full Year 2017 Financial Results 45
Dec 27, 2017: Anika Announces FDA 510(k) Clearance for Its Injectable HA-Based Bone Repair Treatment 45
Oct 25, 2017: Anika Reports Third Quarter 2017 Financial Results 46
Oct 23, 2017: Anika Announces the Forthcoming Appointment of Thomas M. Finnerty as Chief Human Resources Officer 47
Appendix 48
Methodology 48
About GlobalData 51
Contact Us 51
Disclaimer 51

List of Tables
Anika Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview 6
Anika Therapeutics Inc Pipeline Products by Equipment Type 7
Anika Therapeutics Inc Pipeline Products by Indication 8
Anika Therapeutics Inc Ongoing Clinical Trials by Trial Status 8
Anika Therapeutics Inc, Key Facts 9
Anika Therapeutics Inc, Major Products and Services 10
Anika Therapeutics Inc Number of Pipeline Products by Development Stage 12
Anika Therapeutics Inc Pipeline Products Summary by Development Stage 13
Anika Therapeutics Inc Ongoing Clinical Trials by Trial Status 14
Anika Therapeutics Inc Ongoing Clinical Trials Summary 15
Cingal - Product Status 16
Cingal - Product Description 16
Drug Delivery System - Product Status 17
Drug Delivery System - Product Description 17
Hemostatic Patch - Product Status 18
Hemostatic Patch - Product Description 18
HYAFF - Rotator Cuff Repair - Product Status 19
HYAFF - Rotator Cuff Repair - Product Description 19
HYAFF Barrier Film - Product Status 20
HYAFF Barrier Film - Product Description 20
HYAFF Gel - Product Status 21
HYAFF Gel - Product Description 21
HYAFF Mesh - Product Status 22
HYAFF Mesh - Product Description 22
Hyalobone - Product Status 23
Hyalobone - Product Description 23
Hyalofast - Product Status 24
Hyalofast - Product Description 24
Hyalofast - A Prospective, Randomized, Active Treatment-controlled, Evaluator-blinded Multicenter Study to Establish the Superiority of Hyalofast with BMAC in the Treatment of Articular Knee Cartilage Defect Lesions in Comparison to Control 25
Hyaloglide - Product Status 26
Hyaloglide - Product Description 26
Hyalograft C Autograft - Product Status 27
Hyalograft C Autograft - Product Description 27
Hyalonect - Product Status 28
Hyalonect - Product Description 28
Hyaluronic Acid - Synovial Joints - Product Status 29
Hyaluronic Acid - Synovial Joints - Product Description 29
MONOVISC - Product Status 30
MONOVISC - Product Description 30
MONOVISC - Hip - Product Status 31
MONOVISC - Hip - Product Description 31
MONOVISC - Hip - Investigational Device Exemption (IDE) Phase III Study of MONOVISC to Treat Pain Caused by Osteoarthritis of the Hip 32
Next Generation ELEVESS Dermal Filler - Product Status 33
Next Generation ELEVESS Dermal Filler - Product Description 33
ORTHOVISC-T - Product Status 34
ORTHOVISC-T - Product Description 34
SCS 17-01 - Product Status 35
SCS 17-01 - Product Description 35
Anika Therapeutics Inc, Key Employees 37
Anika Therapeutics Inc, Key Employee Biographies 38
Anika Therapeutics Inc, Subsidiaries 39
Glossary 50

List of Figures
Anika Therapeutics Inc Pipeline Products by Equipment Type 7
Anika Therapeutics Inc Pipeline Products by Development Stage 12
Anika Therapeutics Inc Ongoing Clinical Trials by Trial Status 14

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Anika Therapeutics Inc (ANIK):企業の製品パイプライン分析2018(Anika Therapeutics Inc (ANIK) - Product Pipeline Analysis, 2018 Update)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆